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Polycystic ovary syndrome (PCOS) is said to be the most common endocrine disorder in women of reproductive age with a heterogeneous presentation, 
which includes hyperandrogenism and ovulatory dysfunction. PCOS usually has a peripubertal onset; the present review discusses the causes, 
complications, risk factors, diagnosis, and treatment.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder. As 
one of the leading causes of anovulatory infertility, it is believed that 
5-10% of the reproductive-aged female population is living with PCOS. 
First recognized by Stein and Leventhal, in 1935, PCOS is characterized 
by the presence of polycystic ovaries, menstrual irregularities, and 
clinical/biochemical hyperandrogenism. The development of PCOS has 
been linked to hereditary and environmental factors including genetics, 
insulin resistance, obesity, and birth weight. The presence of PCOS is 
associated with an increased prevalence of adverse health conditions 
such as the metabolic syndrome, cardiovascular disease, and Type II 
diabetes mellitus. Insulin resistance is believed to play a key role in 
the development of PCOS and the development of related conditions. 
In the past few years, research has been done to better understand the 
mechanisms behind the development PCOS and the impact it has on the 
female body, particularly in relationship to insulin resistance.
DEFINITION
PCOS is a common endocrine system disorder among women of 
reproductive age. Women with PCOS may have enlarged ovaries 
that contain small collections of fluid called follicles located in 
ovaries and have abnormalities in the metabolism of androgens and 
estrogen (Fig. 1).
TYPES OF PCOS
Type 1 PCOS:  (a) Insulin-resistant PCOS
(b) Non-insulin-resistant types of PCOS
Type 2 PCOS: Pill-induced PCOS or post-pill PCOS
Type 3 PCOS: In lammatory PCOS
Type 4 PCOS: Hidden-cause PCOS
Type 1 PCOS
Insulin-resistant PCOS
In this type of PCOS, insulin resistance and leptin resistance will occur 
due to improper signaling from these metabolic hormones inhibit 
ovulation and cause the ovaries to produce testosterone. It is a problem 
with the metabolic hormones that is the main cause of weight gain. The 
symptoms of excessive testosterone such as acne and facial hair will 
improve when insulin and leptin sensitivity improve.
Causes of Insulin resistance and Type 1 PCOS:
• Leptin resistance
• Too much sugar
• Smoking
• Hormone-disrupting toxins such as Bisphenol A
• Birth control pill.
Non-insulin-resistant types of PCOS
The ultrasound may show multiple, undeveloped follicles. Luteinizing 
hormone (LH) may be elevated, and periods do not occur regularly. 
Testosterone may be high or normal. If testosterone is normal, the 
acne and facial hair exist because estrogen is too low (compared to 
testosterone). Body weight can be normal. In insulin-resistant type, 
the ovaries were prevented from ovulating because of insulin. In other 
types of PCOS, the ovaries are prevented from ovulating because of 
unknown reason.
Type 2 PCOS
Pill-induced PCOS or post-pill PCOS
The birth control pill suppresses ovulation. For most women that are 
a temporary effect and ovulation will usually resume fairly soon after 
the pill is stopped. However, for some women, ovulation-suppression 
can persist for months or even years. During that time, it is not unusual 




Inflammation or chronic immune activation results from stress, 
environmental toxins, intestinal permeability, and inflammatory 
foods such as gluten or A1 casein. Inflammation is a problem for 
PCOS because it impedes ovulation, disrupts hormone receptors, and 
stimulates adrenal androgens such as dehydroepiandrosterone and 
androstenedione.
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Fig. 1: Polycystic ovary syndrome 
Type 4 PCOS
Hidden-cause PCOS
There is one simple thing that is blocking ovulation. Once that single 
thing is addressed, this type of PCOS resolves very quickly, usually 
within 3-4 months. Common hidden-causes of PCOS include:
• Soy, because it is anti-estrogen and can block ovulation in some 
women
• Thyroid disease because your ovaries need T3 thyroid hormone
• Vegetarian diet because it causes zinc de iciency, and ovaries need 
zinc
• Iodine de iciency because ovaries need iodine
• Arti icial sweeteners because they impair insulin and leptin signaling
• Too little starch in diet because the hormonal system needs gentle 
carbs.
EPIDEMIOLOGY
The exact prevalence of PCOS is not known as the syndrome is 
not defined precisely. Globally, prevalence estimates of PCOS are 
highly variable, ranging from 2.2% to as high as 26%. The estimated 
prevalence in women of reproductive age is 5-10%. Under the new 
criteria (Rotterdam, 2003), the prevalence among the general female 
population will raise up to 10%.
ETHIOLOGY/CAUSES
The exact cause of PCOS is unknown, but it is related to abnormal 
hormone levels.
Resistance to insulin
Insulin is a hormone produced by the pancreas to control the amount 
of sugar in the blood. It helps move glucose from the blood into cells, 
where it is broken down to produce energy. Insulin resistance means the 
body’s tissues are resistant to the effects of insulin. The body, therefore, 
has to produce extra insulin to compensate. High levels of insulin cause 
the ovaries to produce too much testosterone hormone, which interferes 
with the development of the follicles (the sacs in the ovaries where eggs 
develop) and prevents normal ovulation. Insulin resistance can also lead 
to weight gain, which can make PCOS symptoms worse because having 
excess fat causes the body to produce even more insulin.
Hormone imbalance
Many women with PCOS are found to have an imbalance in certain 
hormones including:
• Raised levels of testosterone: A hormone often thought of as a male 
hormone, although all women normally produce small amounts of it
• Raised levels of LH: A hormone that stimulates ovulation but may 
have an abnormal effect on the ovaries if levels are too high
• Low levels of sex hormone-binding globulin: A hormone that helps 
reduce the effect of testosterone
• Raised levels of prolactin (only in some women with PCOS): 
A hormone that stimulates the breast glands to produce milk in 
pregnancy.
The exact reason why these hormonal changes occur is not known. It’s 
been suggested that the problem may start in the ovary itself, in other 
glands that produce these hormones, or part of the brain that controls 
their production. The changes may also be caused by the resistance to 
insulin.
Genetics
The methylenetetrahydrofolate reductase (MTHFR) mutation test is 
used to detect two relatively common mutations in the MTHFR gene 
that are associated with elevated levels of homocysteine in the blood 
and also cause hypothyroidism.
RISK FACTORS
• Diabetes
• 4-7 times higher risk of heart attacks




• Risk of endometrial cancer
• Infertility
• Higher rate of miscarriages
• Higher risk of gestational diabetes
• Obesity which can also lead to low self-esteem and depression
• Liver disease.
PATHOPHYSIOLOGY FIGS. 2 AND 3
• Defective sex steroid synthesis and metabolism ovary and adrenal 
gland contribute to steroid production through a similar pathway




• Found in both lean and obese women
• Post-binding defect in insulin-receptor signaling
• Insulin sensitivity is selective and tissue dependent
• Androgen production and/or beta cell defects may exacerbate 
insulin resistance
• Strong predictor of sleep apnea for PCOS patients.
• Hyperinsulinemia results
• Compensatory increase in insulin secretion secondary to 
peripheral insulin resistance.
SIGNS AND SYMPTOMS
The major features of PCOS include menstrual dysfunction, anovulation, 
and signs of hyperandrogenism 70% (hirsutism, acne, and male 
pattern alopecia), anovulation (70-75%) (usually chronic -presents 
as oligomenorrhea and/or amenorrhea, infertility, and recurrent 
miscarriages common).
Other signs and symptoms of PCOS may include the following:
• Obesity (50%)
• Abdominal obesity
• Waist to hip ratio >0.8.
• Diabetes due to insulin resistance (75%)
• Obstructive sleep apnea
• Oligomenorrhea/amenorrhea
• Infertility/ irst-trimester miscarriage
• Acanthosis nigricans.
COMPLICATIONS
• Type 2 diabetes
• High blood pressure
• Cholesterol and lipid abnormalities such as elevated triglycerides or 
low high-density lipoprotein cholesterol, the “good” cholesterol
• Metabolic syndrome – a cluster of signs and symptoms that indicate 
a signi icantly increased risk of cardiovascular disease
• Nonalcoholic steatohepatitis – a severe liver in lammation caused 
by fat accumulation in the liver
• Infertility
• Sleep apnea
• Depression and anxiety
• Abnormal uterine bleeding
• Cancer of the uterine lining (endometrial cancer), caused by exposure 
to continuous high levels of estrogen
• Gestational diabetes or pregnancy-induced high blood pressure.
DIAGNOSIS
On examination, findings in women with PCOS may include the 
following:
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• Enlarged ovaries: May or may not be present; evaluate for an ovarian 
mass.
Testing
Baseline screening laboratory studies for women suspected of having 
PCOS include the following:
• Thyroid function tests (e.g., thyroid-stimulating hormone, free 
thyroxine)
• Serum prolactin level
• Total and free testosterone levels
• Free androgen index
• Serum human chorionic gonadotropin level
• Cosyntropin stimulation test
• Serum 17-hydroxyprogesterone level
• Urinary free cortisol and creatinine levels
• Low-dose dexamethasone suppression test
• Serum insulin-like growth factor-1 level
• Other tests used in the evaluation of PCOS include the following:
• Androstenedione level
• Follicle stimulating hormone and LH levels





The following imaging studies may be used in the evaluation of 
PCOS (Fig. 4):
• Ovarian ultrasonography, preferably using transvaginal approach
• Pelvic computed tomography scan or magnetic resonance imaging 




Surgical management of PCOS is aimed mainly at restoring ovulation. 




Fig. 2: Pathophysiology of polycystic ovary disease
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Selected treatment options for polycystic ovary syndrome







Suppresses LH 9 (and FSH) 
and this ovarian androgen 
production; increase sex 
hormone-binding globulin, which 
decreases free testosterone
One tablet orally daily 
for 21 (or 24) days, 








Menstrual cyclicity Creates withdrawal bleeding 
by transforming proliferative 
endometrium
5-10 mg orally daily 








Decreases hepatic glucose 
production, secondarily reducing 
insulin levels; may have direct 
effects on steroidogenesis
1500 mg orally daily 
in divided doses 










Improves insulin sensitivity 
at target-tissue level (muscle, 
adipocyte); may have direct 
effects on steroidogenesis
Pioglitazone: 15-30 mg 
orally; maximum 45 mg 
orally




Hirsutism, acne Inhibits androgen from binding 
to androgen receptor







Ovulation induction Increase GnRH secretion, which 
induces rise in FSH and LH
50 mg orally for 5 days; 
may increase or 100 mg
Vasomotor symptoms, 
gastrointestinal problems
FSH: Follicle stimulating hormone, GnRH: Gonadotropin-releasing hormone, LH: Luteinizing hormone
Fig. 3: Relationship of gonadotropin secretion, androgen production, and insulin in polycystic ovary disease 9
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Non-pharmacological treatment
• Weight reduction
• Decreasing body weight 5-10% signi icantly reduces 
hyperandrogenism, insulin resistance, and anovulation




• Chemical bleaching and waxing
• Laser removal.
CONCLUSION
Although PCOS is one of the most common endocrine disorders 
in women of reproductive age, there is currently no cure for PCOS. 
For this reason, early diagnosis of the disease based on established 
criteria is important. With an early diagnosis, it is possible to manage 
the manifestations of PCOS. With proper management, obesity and 
insulin resistance can be controlled for as well as the associated 
diseases.
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Fig 5: Laser drilling of ovary
Fig. 4: Ovarian ultrasonography
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